Dr Nisislay Ramos Rodriguez, MD | |
29 Calle Munoz Rivera, Aguadilla, PR 00603-5107 | |
(787) 891-5592 | |
Not Available |
Full Name | Dr Nisislay Ramos Rodriguez |
---|---|
Gender | Female |
Speciality | General Practice |
Location | 29 Calle Munoz Rivera, Aguadilla, Puerto Rico |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1942274014 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208D00000X | General Practice | 9739 (Puerto Rico) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Nisislay Ramos Rodriguez, MD Po Box 306, Aguadilla, PR 00605-0306 Ph: (787) 891-5592 | Dr Nisislay Ramos Rodriguez, MD 29 Calle Munoz Rivera, Aguadilla, PR 00603-5107 Ph: (787) 891-5592 |
News Archive
Asthma is a chronic inflammatory disease driven by the interplay of genetics, environmental factors and a diverse cast of immune cells.
Data presented at the Pediatric Academic Societies, Annual Meeting demonstrate that premature infants with neonatal Respiratory Distress Syndrome (RDS) have a nearly 20% better chance of survival if they are treated with Curosurf, (poractant alfa) Intratracheal Suspension rather than either of two competing surfactant therapies.
Researchers from Belgium and Germany demonstrated how the spike glycoprotein of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is fine-tuned towards the temperature and protease conditions of the human airways, which in turn enhances viral transmission and subsequent pathology. Their study is available on the bioRxiv* preprint server.
Roswell Park Cancer Institute (RPCI) researchers played a leading role in clinical studies which led to U.S. Food and Drug Administration (FDA) approval of a new treatment for patients diagnosed with multiple myeloma - the second most common blood cancer.
MorphoSys AG announced today that it has signed a five-year license agreement with U.S. pharmaceutical company Merck & Co., Inc. for the use of MorphoSys's HuCAL GOLD and AutoCAL technologies in research and development of human therapeutic antibodies.
› Verified 3 days ago
Dr. Jorge Acevedo Canabal, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: 115 Lighthouse Dr, Aguadilla, PR 00603 Phone: 787-403-5576 | |
Kristine Marie Hernandez Ramirez, M.D. General Practice Medicare: Accepting Medicare Assignments Practice Location: 110 Street Km 8.3, Aguadilla, PR 00603 Phone: 787-248-5422 | |
Dr. Farida M Ramos Suarez, MD General Practice Medicare: Medicare Enrolled Practice Location: Carr 2 Km 1225 Bo Caimital Alto, Aguadilla, PR 00603 Phone: 787-891-5482 Fax: 787-891-5482 | |
Mr. William A. Vega-vivas, M.D General Practice Medicare: Medicare Enrolled Practice Location: Carr.111 Km.0.2 Bo. Victoria, Aguadilla, PR 00603 Phone: 787-882-5534 Fax: 787-658-7133 | |
Dr. Johans Gonzalez Gonzalez, M.D. General Practice Medicare: Medicare Enrolled Practice Location: Calle 2 Ave Severino Cuevas 18, Aguadilla, PR 00605 Phone: 787-658-0012 | |
Dr. Jose Ariel Badillo Hernandez, MD General Practice Medicare: Medicare Enrolled Practice Location: Carr # 2 Km 124.7, Edificio Punto Oro Suite 9, Aguadilla, PR 00603 Phone: 787-658-7098 Fax: 787-658-6108 | |
Dr. Bernie Rodriguez-malpica, MD General Practice Medicare: Medicare Enrolled Practice Location: 180-b Belt Rd Ramey Base, Aguadilla, PR 00603 Phone: 787-890-7763 |